Pharmaceutical Sciences and a PhD from Uppsala University. Her research focuses on pharmacometrics and development of population pharmacokinetic and pharmacodynamic models for desired effects and adverse events in a range of therapeutic areas, such as oncology, bacterial infections, schizophrenia, rheumatoid arthritis, and QT prolongation. Currently, most of her research is focused on development of PKPD-models for quantitative, longitudinal predictions of use for translation of drug effects

more »

... m preclinical (in vitro and in vivo) to patients and from early to late clinical development. . He runs a modeling and simulation lab within the School of Pharmacy. Research interests include optimal design, MCMC methods particularly in clinical toxicology and haemostasis. He has been involved in the area of PKPD and nonlinear mixed effects modeling for 20 years. Currently his research involves the development of pharmacological models, modeling of data and the design of clinical studies. These foci essentially revolve around the therapeutic areas of coagulation, malaria and clinical toxicology.